AAV capsid library production

Miguel Chuapoco

Published: 2023-05-23 DOI: 10.17504/protocols.io.5jyl8jyz9g2w/v1

Abstract

We recently developed adeno-associated virus (AAV) capsids to facilitate efficient and noninvasive gene transfer to the central and peripheral nervous systems. However, a detailed protocol for generating and systemically delivering novel AAV variants was not previously available. In this protocol, we describe how to produce and intravenously administer AAVs to adult mice to specifically label and/or genetically manipulate cells in the nervous system and organs, including the heart. The procedure comprises three separate stages: AAV production, intravenous delivery, and evaluation of transgene expression. The protocol spans 8 d, excluding the time required to assess gene expression, and can be readily adopted by researchers with basic molecular biology, cell culture, and animal work experience. We provide guidelines for experimental design and choice of the capsid, cargo, and viral dose appropriate for the experimental aims. The procedures outlined here are adaptable to diverse biomedical applications, from anatomical and functional mapping to gene expression, silencing, and editing.

Before start

Attachments

Steps

Reagent setup: Plasmid DNA

1.

Note
CRITICAL All reagents used for viral production and administration should be prepared usingendotoxin-free materials. Glassware is not endotoxin-free, and autoclaving does not eliminate endotoxins. To minimize contamination, we dissolve chemicals in sterile bottles by shaking and/or heating to mix, use demarcations on bottles to bring solutions to the final volume, and use pH strips rather than a pH meter. When filter-sterilizing solutions, do so in a biosafety cabinet.
Grow bacterial stocks in LB or Plasmid+ media containing the appropriate selective antibiotic; refer

to the Addgene catalog for suggested growth conditions. Use a large-scale endotoxin-free plasmid purification kit to isolate plasmids; elute plasmid DNA with the supplied Tris-EDTA (TE) buffer. Measure the DNA purity and concentration using a spectrophotometer and freeze at -20°C or

-80°C for up to several years.

Note
CRITICAL Always verify the integrity of purified plasmids by Sanger sequencing (using a DNA sequencing facility) and restriction digestion (Always verify the integrity of purified plasmids by Sanger sequencing (using a DNA sequencing facility) and restriction digestion (https://www.neb.com/tools-a nd-resources) before proceeding with downstream applications. pAAV plasmids contain ITRs (Fig. 6) that are prone to recombination in E. coli. pAAVs should be propagated in recombination-deficient strains such as NEB Stable, Stbl3, or SURE 2 competent cells to prevent unwanted recombination. After purification, pAAVs should be digested with SmaI to confirm the presence of ITRs, which are required for replication and encapsidation of the viral genome; use sequence-editing and annotation software to determine the expected band sizes. Note that it is difficult to sequence through the secondary structure of ITRs68; avoid ITRs when designing sequencing primers. nd-resources) before proceeding with downstream applications. pAAV plasmids contain ITRs (Fig. 6) that are prone to recombination in E. coli . pAAVs should be propagated in recombination-deficient strains such as NEB Stable, Stbl3, or SURE 2 competent cells to prevent unwanted recombination. After purification, pAAVs should be digested with SmaI to confirm the presence of ITRs, which are required for replication and encapsidation of the viral genome; use sequence-editing and annotation software to determine the expected band sizes. Note that it is difficult to sequence through the secondary structure of ITRs68; avoid ITRs when designing sequencing primers.Create bacterial glycerol stocks and store at -80°C for up to several years.
Fig. 6 | A modular AAV toolbox for cell type–specific gene expression.
Fig. 6 | A modular AAV toolbox for cell type–specific gene expression.

Reagent setup: Cell culture media

2.

Add

AB
FBS25 ml
NEAA5 ml
pen–strep5 ml
DMEM500-ml bottle

Invert to mix and store at 4°C for up to several months; warm to 37°C before use. The resulting cell culture media should have a final concentration of 5% (vol/vol) FBS, 1× NEAA, and 50 pen–strep.

Note
CRITICAL To quickly expand cells for large viral preps, consider using a final concentration of 10% (vol/vol) FBS in the cell culture media; see guidelines on cell culture below.

Reagent setup: Cell culture

3.

Thaw HEK293T cells according to the manufacturer’s recommendations. Passage cells using either

TrypLE Express enzyme or a standard trypsinization protocol for adherent cultures69. Seed cells in 150-mm tissue culture dishes with a final volume of 20mL of media per dish. Maintain in a cell culture incubator at 37°C with 5% CO2.

Note
CRITICAL We suggest passaging cells at a ratio of 1:3 (i.e., divide one dish of cells into three new dishes of cells) every other day when expanding cells for viral production; split cells at a 1:2 ratio (or 6 × 104 cells/cm2) 24 h before transfection. Use higher split ratios if using 10% (vol/vol) FBS. Always use sterile technique.Follow the manufacterer’s recommendations to create frozen stocks of HEK cells.

Reagent setup: PEI stock solution

4.

Pipette 50mL of WFI water into a 50-ml conical centrifuge tube for later use. Add 323mg of PEI to the remaining 950mL bottle of WFI water and adjust the pH to 2–3 by adding 1 HCl suitable for cell culture, keeping track of the volume of HCl added. Heat in a 37°C water bath for several hours (or 24h 0m 0s) and occasionally shake to mix. Once dissolved, add reserved WFI water to a total volume of 1L. Filter-sterilize, make aliquots in 50-ml conical centrifuge tubes, and store at -20°C for up to 1 year. We routinely freeze–thaw our PEI aliquots.

Note
CRITICAL Both our PEI stock solution recipe and PEI calculations (Supplementary Table 2, ‘Detailed calculations’ sheet) are based on ref. 5. We adjust the pH to 2–3 so that PEI dissolves in water. The designated pH range does not appear to adversely affect cell viability, transfection efficiency, or viral titers. The transfection solution, created by mixing the PEI + DPBS master mix and DNA + DPBS solution (Step 24 and Supplementary Table 2), has a final pH of 6.5–7.0. To transfect one dish, 2mL of transfection solution is added to 20mL of media (Step 24), which further dilutes the PEI.

Reagent setup: PEI + DPBS master mix

5.

Thaw PEI in a 37°C water bath. Bring the PEI to Room temperature (23°C) and vortex to mix. Add PEI and DPBS to a 50-ml conical centrifuge tube and vortex again to mix. Use Supplementary Table 2 (‘Transfection calculator’ sheet) to calculate the volumes of PEI (cell I9) and DPBS (cell J9) needed.

Note
CRITICAL Prepare fresh master mix before use.

Reagent setup: DNA + DPBS

6.

Bring plasmid DNA to Room temperature and briefly vortex to mix. For each viral prep, add DNA and DPBS to a 50-ml conical centrifuge tube; the solution is vortexed in Step 24. Use Supplementary Table 2 (‘Transfection calculator’ sheet) to calculate the quantities of DNA (e.g., cells E9, E11, and E13) and DPBS (e.g., cell F9) needed.

Note
CRITICAL Prepare fresh DNA + DPBS solution before use. Re-measure plasmid DNA concentrations immediately before use; multiple freeze–thaw cycles may cause DNA degradation.

Reagent setup: SAN digestion buffer

7.

Add

AB
NaCl29.22 g
Tris base4.85 g
MgCl2·6H2O2.03 g
WFI water1-liter bottle

and shake to mix. Filter-sterilize and store at Room temperature for up to several months. The resulting SAN digestion buffer should have a final pH of ~10.0 and a final concentration of 500millimolar (mM) NaCl, 40millimolar (mM) Tris base, and 10millimolar (mM) MgCl2.

Reagent setup: SAN + SAN digestion buffer

8.

Add 100 of SAN (4µL of 25 SAN) per milliliter of SAN digestion buffer; pipette to mix.

Note
CRITICAL Prepare fresh solution before use.

Reagent setup: 40% (wt/vol) PEG stock solution

9.

Decant ~500mL of WFI water into a 500-ml sterile bottle for later use. Add 146.1g of NaCl to the remaining 500mL (in the 1-liter bottle of WFI water) and shake/heat until dissolved.

Once completely dissolved, add 400g of PEG and heat at 37°C 24h 0m 0s for up to 2 nights. Add reserved WFI water to a total volume of 1L. Filter-sterilize and store at Room temperature for up to several months. The resulting stock solution should have a final concentration of 2.5Molarity (M) NaCl and 40% (wt/vol) PEG.

Note
CRITICAL Prepare in advance. To expedite the procedure, heat the solution at 65°C until the PEG is dissolved. The solution will appear turbid, but no flecks of PEG should remain; the mixture will become clear upon cooling.Pre-wet the entire filter surface with a minimal volume of water before adding the solution. This solution is extremely viscous and will take 1–2 h to filter.

Reagent setup: DPBS + high salt

10.

Add

AB
NaCl29.22 g
KCl93.2 mg
MgCl2·6H2O101.7 mg
DPBS500-ml bottle

and shake to mix. Filter-sterilize and store at Room temperature for up to several months. The resulting buffer should have a final concentration of 1Molarity (M) NaCl, 2.5millimolar (mM) KCl, and 1millimolar (mM) MgCl2 (in addition to the salts in the DPBS).

Reagent setup: DPBS + low salt

11.

Add

AB
NaCl2.92 g
KCl93.2 mg
MgCl2·6H2O101.7 mg
DPBS500-ml bottle

and shake to mix. Filter-sterilize and store at Room temperature for up to several months. The resulting buffer should have a final concentration of 100millimolar (mM) NaCl, 2.5millimolar (mM) KCl, and 1millimolar (mM) MgCl2 (in addition to the salts in the DPBS).

Reagent setup: Iodixanol density gradient solutions (15%, 25%, 40%, and 60% (wt/vol) iodixanol)

12.

For each layer, add iodixanol (OptiPrep), DPBS + high salt or DPBS + low salt, and phenol red (if

applicable) to a 50-ml conical centrifuge tube. Invert or briefly vortex to mix. Use Supplementary Table 3 to determine the volumes of each reagent needed. The 25% and 60% layers contain phenol red, which turns the solutions red and yellow, respectively, and facilitates clear demarcation of the gradient boundaries (Fig. 8).

Note
CRITICAL Prepare fresh solutions on the day of AAV purification. Alternatively, prepare up to 1 d in advance; store at Room temperature and protect from light. Do not pour the density gradients until Step 38.In Step 38.2, prepare more iodixanol solutions than are needed. For six or fewer gradients, prepare enough of each solution to pour an extra gradient. For eight gradients, prepare enough of each solution to pour two extra gradients. The extra solution is needed to fill the 5-ml pipette and prevent an air bubble from disturbing the gradient when releasing the last of the required volume.
Fig. 8 | AAV purification procedure. a,b, In Step 38, pipette the iodixanol density gradients (Supplementary Video 1, 0:00–1:45, or Supplementary Video 2, 0:00–1:13). a, Layer the 25% (wt/vol) iodixanol underneath the 15% layer. b, Add layers of increasing density under the previous layer; the gradients should have a sharp delineation between layers. c, In Step 40 the supernatant (Sup.) from Step 39 (Fig. 7b) above the 15% layer (Supplementary Video 1, 1:46–2:22; the same step is also shown in Supplementary Video 2, 1:14–1:55). d,e, In Step 41, fill each tube up to the neck with SAN digestion buffer and insert a black cap (d); place a spacer on top before weighing the tubes (e). f, After ultracentrifugation (Step 44), secure the tube into the clamp setup above a container of fresh 10% (vol/vol) bleach (Step 46). Allow 10 ml of DPBS to begin dripping through the syringe filter unit into an Amicon filter device (Step 47). g, In Step 48, collect the virus (Supplementary Video 3, 0:00–1:30). Insert the needle ~4 mm below the 40/60% interface (i.e., where the tube just starts to curve). Do not collect virus (asterisk) until the black cap is removed; do not collect from the white protein layer at the 25/40% interface. h, In Step 49, filter the virus/iodixanol (Supplementary Video 3, 1:31–2:32). Inject the virus below the DPBS in the filter-attached syringe barrel before pushing the virus/DPBS through the syringe filter unit and into the Amicon filter device.
Fig. 8 | AAV purification procedure. a,b, In Step 38, pipette the iodixanol density gradients (Supplementary Video 1, 0:00–1:45, or Supplementary Video 2, 0:00–1:13). a, Layer the 25% (wt/vol) iodixanol underneath the 15% layer. b, Add layers of increasing density under the previous layer; the gradients should have a sharp delineation between layers. c, In Step 40 the supernatant (Sup.) from Step 39 (Fig. 7b) above the 15% layer (Supplementary Video 1, 1:46–2:22; the same step is also shown in Supplementary Video 2, 1:14–1:55). d,e, In Step 41, fill each tube up to the neck with SAN digestion buffer and insert a black cap (d); place a spacer on top before weighing the tubes (e). f, After ultracentrifugation (Step 44), secure the tube into the clamp setup above a container of fresh 10% (vol/vol) bleach (Step 46). Allow 10 ml of DPBS to begin dripping through the syringe filter unit into an Amicon filter device (Step 47). g, In Step 48, collect the virus (Supplementary Video 3, 0:00–1:30). Insert the needle ~4 mm below the 40/60% interface (i.e., where the tube just starts to curve). Do not collect virus (asterisk) until the black cap is removed; do not collect from the white protein layer at the 25/40% interface. h, In Step 49, filter the virus/iodixanol (Supplementary Video 3, 1:31–2:32). Inject the virus below the DPBS in the filter-attached syringe barrel before pushing the virus/DPBS through the syringe filter unit and into the Amicon filter device.

Reagent setup: DNase digestion buffer

13.

Use a 50-ml serological pipette to measure 247.5mL of UltraPure water into a 250-ml sterile bottle. Add

AB
CaCl255.5 mg
1 M Tris-HCl2.5 ml
MgCl2·6H2O508 mg

and shake to mix. Filter sterilize and store at Room temperature for up to several months. The resulting buffer should have a final concentration of 2Molarity (M) CaCl2, 10Molarity (M) Tris-HCl, and 10Molarity (M) MgCl2.

Reagent setup: DNase I + DNase digestion buffer

14.

Add 50 of DNase I per milliliter of digestion buffer (a 1:200 dilution of 10 DNase); pipette to mix.

Note
CRITICAL Prepare fresh solution before use.

Reagent setup: Proteinase K solution

15.

Use a 50-ml serological pipette to measure 250mL of UltraPure water into a 250-ml sterile bottle. Add 14.61g of NaCl and shake to mix. Add 2.5g of N-lauroylsarcosine sodium salt to the mixture and gently swirl to mix; N-lauroylsarcosine sodium salt is a surfactant and will generate bubbles during vigorous mixing. Filter-sterilize and store at Room temperature for up to several months. The resulting solution should have a final concentration of 1Molarity (M) NaCl and 1% (wt/vol) N -lauroylsarcosine sodium salt.

Reagent setup: Proteinase K + proteinase K solution

16.

Add 100µg of proteinase K per milliliter of solution (a 1:200 dilution of 50 (2.5 U/mg) proteinase K); pipette to mix.

Note
CRITICAL Prepare fresh solution before use.

Reagent setup: DNA standard stock

17.

Set up a single 50-μl restriction digest reaction; use 60-80 (3–4 μl) of ScaI (or another suitable enzyme) to linearize 20µg of the plasmid DNA containing the target sequence. Run a small amount of the reaction on an agarose gel to ensure complete digestion. Purify the reaction using two DNA clean-up columns. Measure the DNA concentration (ng/μl) using a spectrophotometer. Dilute to ~5–10 × 109 single-stranded (ss) DNA molecules/μl and use the Qubit assay to verify the concentration (ng/μl). Divide into 20µL aliquots in DNA/RNA LoBind microcentrifuge tubes and freeze at -20°C for up to 1 year.

Note
CRITICAL Before preparing the standard, use sequence-editing and annotation software to confirm that the plasmid contains a single ScaI site in the ampicillin resistance gene. Refer to ref. 11 and use Supplementary Table 4 (cells B7–10) to calculate the number of ssDNA molecules in a given plasmid (cell B13). We typically use linearized pAAV-CAG-eYFP diluted to 10, which corresponds to 6.6 × 109 ssDNA molecules/μl (Supplementary Table 4, ‘Example’ sheet).

Reagent setup: DNA standard dilutions

18.

Prepare three sets of eight (1:10) serial dilutions of the DNA standard stock. For each set, begin by pipetting 5µL of the standard into 45µL of UltraPure water (standard no. 8). Mix by vortexing for 0h 0m 3s and proceed with the seven remaining dilutions (standard no. 7 to standard no. 1). The final concentrations of the standard dilutions should range from 5–10 × 108 (standard no. 8) to 5–10 × 101 (standard no. 1) ssDNA molecules/μl.

Note
CRITICAL Prepare fresh solutions in DNA/RNA LoBind microcentrifuge tubes immediately prior to use; at low concentrations, the linearized DNA is prone to degradation and/or sticking to the walls of the tube11. One 20µL aliquot of the DNA standard stock will provide enough DNA for preparing the dilutions and verifying the concentration via the Qubit assay before qPCR.

Reagent setup: qPCR master mix

19.

Prepare a qPCR master mix for the total number of reactions (i.e., wells) needed. One reaction requires

AB
SYBR Green master mix12.5 μl
UltraPure water9.5 μl
each primer (from a 2.5-μM stock concentration)0.5 μl
Total23 μl/well

Pipette or vortex for 1–2 s to mix.

Note
CRITICAL Prepare fresh solution before use.

Equipment setup: Clamp setup for AAV purification

20.

Attach the rod to the support stand. Secure the clamp 25–30 cm above the stand (Fig. 8f).

Procedure

21.

Safety information
! CAUTION AAVs are biohazardous materials and must be handled according to governmental and institutional regulations. Experiments involving AAVs were performed using biosafety level 2 practices as required by the California Institute of Technology and the US Centers for Disease Control and Prevention.

Note
CRITICAL The entire procedure spans 8 d, excluding pause points and the time required to evaluate transgene expression (Fig. 7a). There are no pause points between days 1 and 5, until Step 33; once cells have been transfected, AAVs are harvested on days 3 and 5. Plan accordingly during this time window.

Procedure: Triple transient transfection of HEK293T cells ● Timing 1–2 h

22.

Note
CRITICAL For capsids that package well (i.e., AAV9, AAV-PHP.B, AAV-PHP.eB, and AAV-PHP.S), the PEI transfection protocol typically yields ≥1 × 1012 vg per 150-mm dish, as measured post purification2,3. Before starting the protocol, determine the number of dishes needed per viral prep and use Supplementary Table 2 (‘Transfection calculator’ sheet) to calculate the quantities of PEI, DPBS, and plasmid DNA required for transfection. Skip to Step 65 if custom AAVs were obtained elsewhere.

24 h before transfection, seed HEK293T cells in 150-mm dishes to attain 80–90% confluency the next day69. Incubate the cells in a cell culture incubator at 37°C with 5% CO2.

23.

At the time of transfection, make the PEI + DPBS master mix and the DNA + DPBS solution for each viral prep (Reagent setup and Supplementary Table 2, ‘Transfection calculator’ sheet). Using a 5- or 10-ml serological pipette, add the required volume of the PEI + DPBS master mix (e.g., ‘Transfection calculator’ cell G9) dropwise to the DNA + DPBS solution (e.g., ‘Transfection calculator’ cells E9 + E11 + E13 + F9) while gently vortexing to mix. Cap the tube and thoroughly vortex for 0h 0m 10s to mix. Allow the mixture to sit at Room temperature for 2–10 min. Add 2mL of the transfection solution dropwise to each dish and swirl to mix before returning the dishes to the cell culture incubator.

Note
CRITICAL STEP We use a AAV2/9 REP-AAP-ΔCAP:pUC18:pHelper plasmid ratio of 1:1:2 based on micrograms of DNA. We use 40µg of total DNA per 150-mm dish (9.98µg of AAV2/9 REP-AAP-ΔCAP, 9.98µg of pUC18, and 19.97µg of pHelper). Additionally, we add 10ngof t he plasmid-safe DNase treated library per 150-mm dish.The transfection solution will appear slightly cloudy because of the formation of DNA–PEI complexes5,6. Allowing the mixture to sit for >10 min may reduce transfection efficiency. ? TROUBLESHOOTING

24.

Change the media 12–24 h post transfection by aspirating the old media in 10% (vol/vol) bleach and replacing it with 20mL of fresh, warmed media (Reagent setup).

Note
CRITICAL STEP Do not allow the cells to remain without media for more than a few minutes. To protect the cells from unwanted stress, aspirate the media from five plates at a time and promptly replace it with new media. PEI is moderately cytotoxic6 and cell death of up to 20% is common71. Do not allow the media to remain unchanged for more than 24 h post transfection. Failure to change the media in a timely manner will result in poor cell health and low titers. Beginning 72 h post transfection, examine the cells under a fluorescence microscope to assess fluorescent protein expression, if applicable. Note that expression of the rAAV genome does not necessarily correlate with final viral yield and will depend on the reporter and/or promoter under investigation. ? TROUBLESHOOTING

Procedure: AAV harvest ● Timing 3 d

25.

Harvest the media and cells 60 h (2.5 d) post-transfection. Use a cell scraper to gently scrape the cells in the media. After scraping the first dish, prop it at a 30° angle, using an empty 1.5-ml microcentrifuge tube rack for support. Scrape down the residual cells and media such that they are pooled together. Return the dish lid and scrape the next plate; prop dishes up against one another along the length of the biosafety cabinet until scraping is complete. Use a 25-ml serological pipette to collect the media and cells from each dish; transfer to a 250-ml conical centrifuge tube. Pool the media and cells from up to 10 dishes in a single tube.

Note
! CAUTION Scrape the cells with a forward motion (i.e., away from the front grill of the biosafety cabinet) to prevent media and cells from splashing out of the biosafety cabinet. If a spill does occur at this or any other step, immediately cover with paper towels and carefully saturate the towels with fresh 10% (vol/vol) bleach. CRITICAL STEP To avoid cross-contamination, harvest the media and cells from one viral prep at a time. For larger viral preps (6–10 dishes), a 250- or 500-ml conical centrifuge tube can be used to harvest the media and cells (Steps 27–31). However, we recommend using two 250-ml tubes in Step 32.2 because the PEG pellet (Step 34) is difficult to remove from the walls and edges of 500-ml tubes (Step 36).

26.

Centrifuge the media and cells at 2000x g. Ensure that the tube caps are tightly secured. Centrifugation will result in the formation of a cell pellet (Fig. 7b).

27.

Pour off the supernatant (i.e., the clarified media) into the corresponding bottle from Step 26. Allow excess media to drip back down onto the beveled edge of the 250-ml tube; remove using a P1000 pipette and add to the supernatant. Store the supernatant at 4°C until Step 32.

Note
CRITICAL STEP Failure to remove excess media from the pellet will cause several milliliters of media to dilute the SAN digestion buffer in Step 31.

28.

Cell pellet resuspension. Prepare 5mL of SAN + SAN digestion buffer (Reagent setup) per viral prep. For smaller viral preps (1–5 dishes), use option 31.1. For larger preps (6–10 dishes), use option 31.2.

28.1.

Harvest from 1–5 dishes

  1. Use a 5-ml serological pipette to gently resuspend the cell pellet in 5mL of SAN + SAN digestion buffer; pipette into a 50-ml tube to finish resuspending the pellet (Fig. 7b).
  2. Incubate in a 37°C water bath for 1h 0m 0s and store at 4°C until Step 36 (up to 1 d).
    Note
    CRITICAL STEP Be sure to collect the entire pellet, which will stick to the walls and beveled edges of 250-ml tubes. Save the 250-ml tubes for Step 32.The high salt content of SAN digestion buffer lyses the cells, which release the viral particles and nucleic acids into the solution. Initially, the cell lysate may be viscous and difficult to pipette; SAN will degrade nucleic acids and reduce the viscosity after incubation at 37°C. The pH of the lysate will decrease to 8–9 or lower during cell lysis, but the lysate should appear pink rather than yellow/orange because of residual phenol red (Fig. 7b). Note that the expression of fluorescent proteins from strong promoters (e.g., CAG) can alter the color of the lysate.(Optional ) Collect a 30µL sample from the cell lysate for troubleshooting; store at 4°C for up to 1 week. If the viral yield is lower than expected, the sample can be titered (Steps 54–64) to determine at which stage the virus may have been lost.? TROUBLESHOOTING
28.2.

Harvest from 6–10 dishes

  • Use a 10-ml serological pipette to partially resuspend the smaller cell pellet in 5mL of SAN + SAN digestion buffer. Pipette into the second 250-ml tube containing the larger pellet and resuspend together; pipette into a 50-ml tube to finish resuspending the pellet (Fig. 7b).
  • Incubate in a 37°C water bath for 1h 0m 0sand store at 4°C until Step 36 (up to 1 d).
    Note
    CRITICAL STEP Be sure to collect the entire pellet, which will stick to the walls and beveled edges of 250-ml tubes. Save the 250-ml tubes for Step 32.The high salt content of SAN digestion buffer lyses the cells, which release viral particles and nucleic acids into solution. Initially, the cell lysate may be viscous and difficult to pipette; SAN will degrade nucleic acids and reduce the viscosity after incubation at 37°C. The pH of the lysate will decrease to 8–9 or lower during cell lysis, but the lysate should appear pink rather than yellow/orange because of residual phenol red (Fig. 7b). Note that expression of fluorescent proteins from strong promoters (e.g., CAG) can alter the color of the lysate.(Optional ) Collect a 30µL sample from the cell lysate for troubleshooting; store at 4°C for up to 1 week. If the viral yield is lower than expected, the sample can be titered (Steps 54–64) to determine at which stage the virus may have been lost.? TROUBLESHOOTING
29.

Retrieve the supernatant collected in Step 30. For smaller viral preps (1–5 dishes), use option 32.1. For larger preps (6–10 dishes), use option 32.2.

29.1.

Harvest from 1–5 dishes

Pour the supernatant from Step 30 into the corresponding 250-ml tube from Step 31.

Note
CRITICAL STEP (Optional ) Collect a 30µL sample from the media for troubleshooting; store at 4°C for up to 1 week. If the viral yield is lower than expected, the sample can be titered (Steps 54–64) to determine at which stage the virus may have been lost.

29.2.

Harvest from 6–10 dishes

Equally divide the supernatant from Step 30 between the two corresponding 250-ml tubes from Step 31.

Note
CRITICAL STEP (Optional ) Collect a 30µL sample from the media for troubleshooting; store at 4°C for up to 1 week. If the viral yield is lower than expected, the sample can be titered (Steps 54–64) to determine at which stage the virus may have been lost.

30.

Use a 25-ml or 50-ml serological pipette to add a 1/5 final volume of 40% (wt/vol) PEG stock solution to the supernatant (i.e., the supernatant should contain a final concentration of 8% (wt/vol) PEG solution). Tighten the cap and thoroughly invert ten times to mix. Incubate On ice for 2h 0m 0s.

Note
CRITICAL STEP For AAV production in HEK293T cells, the cell culture media contains a large fraction of the expected yield72. Failure to PEG-precipitate AAV particles in the media will result in lower viral yields8.PAUSE POINT The PEG–media mixture can be incubated at 4°C 2h 0m 0s.

31.

Centrifuge the PEG–media mixture at 4000x g,4°C. Centrifugation will result in the formation of a PEG pellet (Fig. 7b).

32.

Pour off the supernatant (i.e., the PEG-clarified media) into a used media collection bottle for bleaching. Allow excess media to drip back down onto the beveled edge of the 250-ml tube; aspirate or pipette to remove.

33.

PEG pellet resuspension. Prepare 1mL of SAN + SAN digestion buffer (Reagent setup) per viral prep. For smaller viral preps (1–5 dishes), use option 36.1. For larger preps (6–10 dishes), use option 36.2.

33.1.

Harvest from 1–5 dishes

  1. Use a P1000 pipette to carefully resuspend the PEG pellet in 1mL of SAN + SAN digestion buffer; pipette into the corresponding lysate from Step 31 (Fig. 7b).
  2. Incubate in a 37°C water bath for an additional 0h 30m 0s.
    Note
    CRITICAL STEP Resuspending the PEG pellet is difficult and will take ~0h 5m 0s per pellet. Be sure to collect the entire pellet, some of which will stick to the walls and beveled edges of 250-ml tubes. During resuspension, avoid air bubbles, which can be difficult to collect with a pipette and may disrupt capsid structure. Do not use a serological pipette to resuspend the pellet, which can become lodged within the barrel of the pipette.(Optional ) Collect a 30µL sample from the PEG pellet resuspension, before adding it to the corresponding lysate, for troubleshooting; store at 4°C for up to 1 week. If the viral yield is lower than expected, the sample can be titered (Steps 54–64) to determine at which stage the virus may have been lost.PAUSE POINT Store the lysate at 4°C 0h 5m 0s. Alternatively, use a dry ice–ethanol bath to freeze the lysate; store at -20°C for up to 1 week.
33.2.

Harvest from 6–10 dishes

  1. Use a P1000 pipette to partially resuspend one of the PEG pellets in 1mL of SAN + SAN digestion buffer. Pipette into the second 250-ml tube containing the second pellet and carefully resuspend together; pipette into the corresponding lysate from Step 31 (Fig. 7b).
  2. Incubate in a 37°C water bath for an additional 0h 30m 0s.
    Note
    CRITICAL STEP Resuspending the PEG pellet is difficult and will take ~0h 5m 0s per pellet. Be sure to collect the entire pellet, some of which will stick to the walls and beveled edges of 250-ml tubes. During resuspension, avoid air bubbles, which can be difficult to collect with a pipette and may disrupt capsid structure. Do not use a serological pipette to resuspend the pellet, which can become lodged within the barrel of the pipette.(Optional ) Collect a 30µL sample from the PEG pellet resuspension, before adding it to the corresponding lysate, for troubleshooting; store at 4°C for up to 1 week. If the viral yield is lower than expected, the sample can be titered (Steps 54–64) to determine at which stage the virus may have been lost.PAUSE POINT Store the lysate at 4°C 0h 0m 0s. Alternatively, use a dry ice–ethanol bath to freeze the lysate; store at -20°C for up to 1 week.

Procedure: AAV purification ● Timing 1 d

34.

Note
CRITICAL One iodixanol density gradient is sufficient to purify virus from up to ten 150-mm dishes. If more than ten dishes per prep are used, divide the lysate into more than one gradient. The AAV purification steps are most easily learned by visualization; refer to Fig. 8 and Supplementary Videos 1–3 for details.
Determine the number of gradients needed and prepare the iodixanol density gradient solutions (Reagent setup and Supplementary Table 3). Set the OptiSeal tubes in the rack provided in the OptiSeal tube kit; alternatively, use the long edge of a 50-ml tube Styrofoam rack.

Note
CAUTION Check the OptiSeal tubes for defects; tubes with dents may collapse during ultracentrifugation.

35.

Pour the density gradients (Fig. 8a,b and Supplementary Video 1, 0:00–1:45, or Supplementary Video 2, 0:00–1:13). Each gradient is composed of the following layers: 6mL of 15% (wt/vol) iodixanol, 6mL of 25% (wt/vol) iodixanol, 5mL of 40% (wt/vol) iodixanol, and 5mL of 60% (wt/vol) iodixanol (Supplementary Table 3). Pour the layers with a 2- or 5-ml serological pipette. We typically use a 2-ml pipette; using a 5-ml pipette is faster but requires the use of PTFE and Tygon tubing and extra reagents. To load the layers with a 2-ml pipette, choose option 38.1. To load the layers with a 5-ml pipette, choose option 38.2.

35.1.

Loading with a 2-ml pipette

Begin by pipetting 6mL (measure to the 3 ml mark twice) of 15% (wt/vol) iodixanol to each tube. Next, add 6mL of 25% (wt/vol) iodixanol under the 15% layer by lightly touching the pipette tip to the bottom of the tube and slowly releasing the solution (Fig. 8a and Supplementary Video 1, 0:13–1:29). Continue adding layers of increasing density under the previous layer. The gradients should have a sharp delineation between layers (Fig. 8b).

Note
CRITICAL STEP When loading the 25%, 40%, and 60% layers with a 2-ml pipette, stop releasing the solution and slowly remove the pipette once the iodixanol is ~5 mm from the tip of the pipette (Supplementary Video 1, 0:42–0:58 and 1:20–1:25). This will prevent an air bubble from disturbing the gradient. The remaining iodixanol will be released when the pipette is removed from the tube.Corning brand 2-ml serological pipettes consistently fit into OptiSeal tubes; other brands should be tested before use.? TROUBLESHOOTING

35.2.

Loading with a 5-ml pipette

Attach a piece of tubing (see Equipment) to a 5-ml pipette. Begin by pipetting 6mL of 15% (wt/vol) iodixanol into each tube. Next, add 6mL of 25% (wt/vol) iodixanol under the 15% layer by lightly touching the tubing to the bottom of the tube and slowly releasing the solution (Supplementary Video 2, 0:17–1:13). Continue adding layers of increasing density under the previous layer. The gradients should have a sharp delineation between layers (Fig. 8b).

Note
CRITICAL STEP Fill the 5-ml pipette with more layer solution than is needed (e.g., an extra 1 ml per layer); this will prevent an air bubble from disturbing the gradient when releasing the last of the required volume (Supplementary Video 2, 1:09–1:11). Remember to prepare extra solution (Reagent setup).? TROUBLESHOOTING

36.

Centrifuge the lysate from Step 36 at 2000x g. Centrifugation will result in the formation of a pellet (Fig. 7b).

37.

Use a 2-ml serological pipette to load the supernatant (i.e., the clarified lysate) (~6–7 ml total) from Step 39 above the 15% (wt/vol) iodixanol layer (Fig. 8c and Supplementary Video 1, 1:46–2:22 or Supplementary Video 2, 1:14–1:55). Touch the pipette tip to the surface of the 15% layer and slowly release the lysate such that a layer forms on top.

Note
CRITICAL STEP Use a pipetting device with precise control. Do not allow the lysate to drip from the pipette tip onto the 15% layer; this will cause the lysate to mix with the gradient. Note that Corning brand 2-ml serological pipettes consistently fit into OptiSeal tubes; other brands should be tested before use.The pellet may be soft, making it difficult to retrieve all of the supernatant. After loading 6-7mL of lysate above the 15% layer, spin the lysate for an additional 3000x g,Room temperature,0h 15m 0s; use a P200 or P1000 pipette to slowly load the remaining supernatant onto the lysate layer. Discard the pellet in 10% (vol/vol) bleach or a biohazard waste bin.(Optional ) Collect a 30µL sample from the lysate for troubleshooting; store at 4°C for up to 1 week. If the viral yield is lower than expected, the sample can be titered (Steps 54–64) to determine at which stage the virus may have been lost.

38.

Using a 2-ml serological pipette, fill each tube up to the neck with SAN digestion buffer. Firmly insert a black cap (Fig. 8d) and place a spacer on top (Fig. 8e). Caps and spacers are provided with the OptiSeal tubes and in the OptiSeal tube kit, respectively.

Note
! CAUTION Overfilling the tube can cause a spill when inserting the black cap. Handling the tubes without caps, or with loosely fitted caps, can also cause spills.Avoid air bubbles, which can cause the OptiSeal tubes to collapse during ultracentrifugation.CRITICAL STEP The black cap should fit right above or touch the lysate.

39.

Weigh the tubes with the caps and spacers on. Balance the tubes to within 5-10mg of each other using SAN digestion buffer. Be sure to adjust the tube weight in the biosafety cabinet; use the tube removal tool provided with the OptiSeal tube kit to remove the black cap and add the appropriate volume of SAN digestion buffer with a P20 or P200 pipette.

Note
! CAUTION Failure to balance the tubes before ultracentrifugation could result in damaged equipment.

40.

Place the ultracentrifuge rotor in the biosafety cabinet. Load the tubes and fasten the lid.

Note
! CAUTION Ensure that the rotor is in proper working order. This includes checking that the o-rings are intact, as cracked o-rings can cause virus to spill during ultracentrifugation. Also, check that the rotor and tubes are completely dry; moisture between tubes and the tube cavity can cause tubes to collapse. To prevent damage to the rotor, set it on a paper towel so that the overspeed disk at the bottom is not scratched.

41.

Carefully transfer the rotor to the ultracentrifuge. Spin the Type 70 Ti rotor at 350000x g,18°C (58,400 r.p.m.) with slow acceleration (no. 3; the instrument will take 3 min to accelerate to 500 r.p.m., followed by maximum acceleration) and deceleration (no. 9; the instrument will deccelerate at maximum speed until it reaches 500 r.p.m., then take 6 min to stop) profiles. Alternatively, a Type 60 Ti rotor can be used at 358000x g,0h 0m 0s (59,000 r.p.m.).

Note
! CAUTION Always follow the manufacturer’s instructions while operating an ultracentrifuge.

42.

During ultracentrifugation, gather the supplies and equipment for Steps 46–49. Assemble the clamp setup (Equipment setup) and collect one of each of the following per gradient: Amicon Ultra-15 centrifugal filter device, 5-ml syringe, 10-ml syringe, 0.22-μm syringe filter unit, and a 16-gauge needle.

43.

After ultracentrifugation, bring the rotor inside the biosafety cabinet and remove the lid. Use the spacer removal tool provided with the OptiSeal tube kit to remove the spacer from the first tube. Next, use the tube removal tool to grip the tube neck. Slowly remove the tube from the rotor and secure it into the clamp setup above a 500-ml or 1-liter beaker containing fresh 10% (vol/vol) bleach (Fig. 8f). Clean the side of the tube with a paper towel or a Kimwipe sprayed with 70% (vol/vol) ethanol.

Note
! CAUTION The black cap may become dislodged from the tube during removal, increasing the likelihood of a spill. Try replacing the cap before removing the tube from the rotor. Otherwise, replace the cap once the tube is secured in the clamp setup. If a tube collapses during ultracentrifugation, take extra care when removing the tube from the rotor. Use fresh 10% (vol/vol) bleach to wipe the tube before proceeding with AAV purification. Viruses purified from collapsed tubes may have lower yields. ? TROUBLESHOOTING

44.

Prepare the supplies for Steps 48 and 49. First, remove and save the plunger from a 10-ml syringe. Attach a 0.22-μm syringe filter unit to the syringe barrel and place it on top of an Amicon filter device. Next, add 10mL of DPBS to the barrel and allow the solution to begin dripping through the syringe filter unit and into the filter device (Fig. 8f). Last, attach a 16-gauge needle to a 5-ml syringe.

Note
CRITICAL STEP Amicon filter devices contain traces of glycerine. If this interferes with downstream applications, rinse the device with DPBS before use. (Optional ) Rinse the filtration membrane of the Amicon filter device by adding 15mL of DPBS to the top chamber and centrifuging at 3000x g,Room temperature,0h 1m 0s; discard the flow-through. The manufacterer recommends using the device immediately after rinsing.

45.

From the tube clamped in Step 46, collect the virus from the 40/60% interface and 40% layer9,10 (Fig. 8g and Supplementary Video 3, 0:00–1:30). Hold the top of the OptiSeal tube with your nondominant hand; use your dominant hand to hold the needle/syringe. Use a forward-twisting motion to insert the needle ~4 mm below the 40/60% interface (i.e., where the tube just starts to curve). Use the tube removal tool in your non-dominant hand to remove the black cap from the tube to provide a hole for air entry. With the needle bevel up, use the needle/syringe to collect 4.0–4.5 ml of virus/ iodixanol from the 40/60% interface and 40% layer. Do not collect from the white protein layer at the 25/40% interface; as this interface is approached, rotate the needle bevel down and continue collecting from the 40% layer. Firmly replace the black cap before removing the needle from the tube.

Safety information
! CAUTION Keep your hands out of the path of the needle to prevent accidental exposure to AAVs. Failure to firmly replace the black cap before removing the needle will cause the AAV contaminated solution to flow out of the needle hole in the tube and potentially onto and out of the biosafety cabinet. Perform this step over a large beaker of fresh 10% (vol/vol) bleach (Fig. 8f).

Note
CRITICAL STEP The virus should concentrate at the 40/60% interface and within the 40% layer10. There will not be a visible virus band, but the phenol red in the 25% and 60% layers helps to better define the 40% cushion. Before attempting to collect virus from the density gradient, practice on an OptiSeal tube filled with water. (Optional ) Collect a 30µL sample from the virus/iodixanol for troubleshooting; store at 4°C for up to 1 week. If the viral yield is lower than expected, the sample can be titered (Steps 54–64) to determine at which stage the virus may have been lost. ? TROUBLESHOOTING

46.

Add the 4.0-4.5mL of virus/iodixanol to the syringe barrel containing 10mL of DPBS (prepared in Step 47) (Fig. 8h and Supplementary Video 3, 1:31–2:06). Layer the virus below the DPBS by placing the needle near the bottom of the barrel and pressing on the plunger. Insert the 10-ml syringe plunger into the barrel and push the virus/DPBS mixture through the syringe filter unit and into the Amicon filter device (Supplementary Video 3, 2:07–2:32). Mix well using a P1000 pipette.

Note
CRITICAL STEP This filtration step reduces the likelihood of clogging the filtration membrane in the Amicon filter device. The virus/iodixanol mixture will be difficult to push through the syringe filter unit; DPBS will be easy to push through as it washes the filter. AAVs adhere to hydrophobic surfaces, including plastics; use low-binding pipette tips (Reagents). Pluronic F-68 is a nonionic surfactant that may reduce virus loss associated with sticking to plastics. (Optional ) Include 0.001% (vol/vol) Pluronic F-68 in the DPBS for Steps 49–52.

47.

Centrifuge the virus/DPBS mixture at 3000x g,0h 0m 0s for 5–8 min, or until the volume of the solution remaining in the top chamber of the Amicon filter device is 500-1500µL (>10× concentrated).

Note
CRITICAL STEP This step may take longer because iodixanol initially slows the passage of the solution through the filtration membrane.

48.

Discard the flow-through for bleaching. Add 13mL of DPBS to the virus in the top chamber and use a P1000 pipette to mix.

Note
CRITICAL STEP Remove the filter device, which contains the virus, before discarding the flow-through.

49.

Centrifuge the virus/DPBS mixture as in Step 50. Wash the virus two more times for a total of four buffer exchanges. During the last spin, retain 300-500µL of solution in the top chamber.

Note
CRITICAL STEP The third and fourth washes may require only a 2–3-min spin until the desired volume remains in the top chamber. The volume retained in the top chamber will affect the final virus concentration (vg/ml) (i.e., the lower the volume, the higher the concentration). A final volume of 300-500µL should work for most applications, assuming a production efficiency of at least 1 × 1012 vg/dish and a dose and injection volume of no more than 1 × 1012 vg and 100µL, respectively (see ‘Experimental design’ section and Step 65 for dose and injection volume recommendations, respectively). For direct injections, a final volume of 200µL may be optimal. Note that retaining too low a volume may cause the virus to aggregate during storage at 4°C (see Step 64 for details).

50.

Use a P200 pipette to transfer the virus from the top chamber of the Amicon filter device directly to a 1.6-ml screw-cap vial; store at 4°C.

Note
CRITICAL STEP Amicon filter devices are not sterile. If this is a concern for specific applications, the virus can be filter-sterilized before storage. (Optional ) Filter-sterilize the virus. Use a P200 pipette to transfer the virus from the top chamber of the Amicon filter device directly to a Costar Spin-X filter unit within a centrifuge tube. Centrifuge the virus at 3000x g,Room temperature,0h 1m 0s. Discard the filter unit and transfer the purified virus from the centrifuge tube to a 1.6-ml screw-cap vial; store at 4°C. The screw-cap vials are not low protein binding; however, they help prevent the formation of aerosols when opening and closing the tubes. We store AAVs in screw-cap vials at 4°C and typically use them within 3 months, during which time we have not noticed a decrease in titers or transduction efficiency in vivo. We have not rigorously tested the effects of long-term storage at -20°C or -80°C for systemically delivered viruses. ? TROUBLESHOOTING PAUSE POINT Store the purified virus at 4°C for up to 3 months.

Procedure: AAV titration ● Timing 1 d

51.

Note
CRITICAL The AAV titration procedure below is adapted from ref. 11. Each virus sample is prepared in triplicate in separate 1.5-ml DNA/RNA LoBind microcentrifuge tubes and later loaded into a 96-well plate for qPCR. All solutions must be accurately pipetted and thoroughly mixed; qPCR is highly sensitive to small changes in DNA concentration.
Prepare a plan for the PCR plate setup. Allocate the first 24 wells (A1–B12) for the DNA standards such that standard no. 1 occupies wells A1–A3, standard no. 2 occupies wells A4–A6, and so on. Use the remaining wells for the virus samples such that the first virus sample occupies wells C1–C3, the second sample occupies wells C4–C6, and so on.

Note
CRITICAL STEP Include DPBS as a negative control and a virus sample with a known concentration as a positive control; prepare the controls with the virus samples in Steps 55–62.

52.

Use DNase I to digest DNA that was not packaged into the viral capsid. Prepare DNase I + DNase digestion buffer (Reagent setup) and add 100µL to each 1.5-ml tube. Vortex each virus for 1–2 s to mix; alternatively, use a P200 pipette to mix. Add 2µL of the virus to each of three tubes. Vortex for 1–2 s to mix and spin down (2000x g); incubate in a 37°C water bath for 1h 0m 0s.

Note
CRITICAL STEP Do not vortex/pipette the virus vigorously or vortex longer than 1–2 s; exposure to force may disrupt capsid structure. When dipping the pipette tip into the virus stock, insert the tip just below the surface of the liquid rather than dipping it deep inside. Excess virus carried on the outside of the tip will carry over into the DNase digestion buffer and cause variations in the titer. Prepare each virus sample in triplicate.

53.

Inactivate the DNase. Add 5µL of EDTA to each tube; vortex for 1–2 s to mix, spin down (2000x g), and incubate in a 70°C dry bath for 0h 10m 0s.

Note
CRITICAL STEP DNase must be inactivated or else it will degrade the viral genome when it is released from the viral capsid in Step 57.

54.

Use proteinase K to digest the viral capsid and release the viral genome. Prepare proteinase K + proteinase K solution (Reagent setup) and add 120µL to each tube. Vortex for 1–2 s to mix and spin down (2000x g); incubate in a 50°C dry bath for 2h 0m 0s.

Note
PAUSE POINT Samples can be incubated at 50°C 0h 10m 0s.

55.

During the last 20 min of the proteinase K digestion, prepare the DNA standard dilutions (Reagent setup) and use the Qubit assay to measure the concentration (ng/μl) of the DNA standard stock.

Note
CRITICAL STEP The concentration of the standard stock solution is used to generate the standard curve after qPCR (Supplementary Table 4, cell B9). To measure the concentration of the standard stock solution, use the Qubit fluorometer, which measures low DNA concentrations with high sensitivity and accuracy.

56.

Inactivate the proteinase K. Incubate the tubes in a 95°C dry bath for 0h 10m 0s.

Safety information
! CAUTION Tube caps may pop open unexpectedly; use safety glasses while removing the tubes from the 95°C dry bath.

Note
CRITICAL STEP Proteinase K must be inactivated or else it will digest the DNA polymerase during qPCR.

57.

Allow the tubes to cool for 0h 5m 0s. Vortex each sample for 1–2 s to mix and add 3µL to a new tube containing 897µL of UltraPure water (a 1:300 dilution). Vortex the diluted samples for 0h 0m 3s to mix.

58.

Prepare the qPCR master mix (Reagent setup).

59.

Load the PCR plate based on the experimental plan from Step 32. First, pipette 23µL of qPCR master mix into each designated well. Next, pipette 2µL of each standard into wells A1–B12. Last, pipette 2µL of each diluted sample from Step 38 into wells C1 and onward. Seal the plate with sealing film and briefly spin down (500x g) in a plate spinner.

60.

Place the PCR plate into the qPCR machine. Use the following cycling parameters:

Step 63.1: `95°C`, `0h 10m 0s`



Step 63.2: `95°C`, `0h 0m 15s`



Step 63.3: `60°C`, `0h 0m 20s`



Step 63.4: `60°C`, `0h 0m 40s`



Repeat steps 63.2–63.4 40×.
61.

When the qPCR run is complete, export the cycle threshold (Ct) values to an Excel file. Copy and paste the Ct values into Supplementary Table 4 (‘AAV titration calculator’ sheet) to generate a standard curve and calculate the titer (vg/ml) (cell G27) of each virus; calculate per-plate production (vg/dish) (cell K27) to assess production efficiency. Be sure to enter the appropriate values in cells B7–10 and B18; see ‘Example’ sheet.

Note
CRITICAL STEP If the titer is ≥1 × 1014 vg/ml, the virus may aggregate during storage at 4°C. Dilute the virus to between 2 × 1013 and 5 × 1013 vg/ml with DPBS and re-titer the diluted stock.? TROUBLESHOOTING

推荐阅读

Nature Protocols
Protocols IO
Current Protocols
扫码咨询